Although the physiological role of adiponectin has not yet been fully elucidated, this protein has been implicated in the pathophysiology of obesity−related insulin resistance, glucose intolerance, insulin−mediated lipoprotein metabolism, atherosclerosis, and coronary heart disease (1, 7, 8, 12, 13, 22). Here, ADIPOQ is linked to coronary artery disorder.